| Sep'19 | Sep'18 | Sep'17 | Sep'16 | Sep'15 | ||
|---|---|---|---|---|---|---|
Collaboration revenues | ||||||
8,146 | 3,087 | 3,811 | 2,979 | 5,219 | ||
Operating expenses: | ||||||
Research and development | ||||||
23,805 | 18,504 | 23,809 | 32,763 | 38,876 | ||
General and administrative | ||||||
9,369 | 14,227 | 15,882 | 21,563 | 12,905 | ||
Impairment of property and equipment | ||||||
11,300 | 0 | - | - | - | ||
Total operating expenses | ||||||
44,445 | 32,731 | 39,691 | 54,326 | 51,781 | ||
Loss from operations | ||||||
-36,299 | -29,644 | -35,880 | -51,347 | -46,562 | ||
Interest expense, net | ||||||
3,466 | 3,891 | 5,625 | 1,851 | 2,297 | ||
Loss on extinguishment of debt | ||||||
-607 | -1,252 | - | - | - | ||
Change in fair value of warrant liability | ||||||
-2,438 | -1,047 | -3,158 | - | - | ||
Loss before income taxes | ||||||
-37,934 | -33,740 | -38,347 | -53,198 | -48,859 | ||
Income tax benefit | ||||||
-3,411 | -3,648 | 501 | 103 | -190 | ||
Net loss | ||||||
- | - | - | - | -48,669 | ||
Less: Net loss attributable to noncontrolling interests | ||||||
- | - | - | - | -1,276 | ||
Net loss | ||||||
-34,523 | -30,091 | -38,849 | -53,301 | -47,393 | ||
Beneficial conversion feature upon issuance of Series A-1 convertible preferred stock | ||||||
61 | 16,022 | 1,176 | - | - | ||
Series A-1 convertible preferred stock dividends and related settlement | ||||||
624 | 1,903 | - | - | - | ||
Deemed dividend upon modification of warrants | ||||||
829 | - | - | - | - | ||
Accretion of redeemable preferred stock and noncontrolling interests | ||||||
- | - | - | 2,463 | 4,306 | ||
Deemed dividends upon the repurchase of Series A redeemable preferred stock and redeemable noncontrolling interests | ||||||
- | - | - | - | 1,298 | ||
Deemed dividend upon issuance of warrants to common stockholders | ||||||
- | - | - | 7,373 | - | ||
Net loss attributable to common stockholders | ||||||
-36,039 | -48,018 | -40,025 | -63,138 | -52,998 | ||
Per share information: | ||||||
Net loss per share of common stock, basic (in dollars per share) | ||||||
- | - | -1.67 | -3.67 | - | ||
Net loss per share of common stock, diluted (in dollars per share) | ||||||
- | - | -1.80 | -3.67 | - | ||
Weighted average shares outstanding, basic (in shares) | ||||||
- | - | 24,022 | 17,212 | - | ||
Weighted average shares outstanding, diluted (in shares) | ||||||
- | - | 24,041 | 17,212 | - | ||
Net loss per share of common stock, basic and diluted (in dollars per share) | ||||||
-1.98 | -9.74 | - | - | -5.43 | ||
Weighted average shares outstanding, basic and diluted (in shares) | ||||||
18,191 | 4,932 | - | - | 9,753 | ||